 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.6.5.1.1
- Dna ligase (ATP).
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + (deoxyribonucleotide)(n) + (deoxyribonucleotide)(m) = AMP + diphosphate + (deoxyribonucleotide)(n+m)
|
 |
 |
 |
 |
 |
ATP
|
+
|
(deoxyribonucleotide)(n)
|
+
|
(deoxyribonucleotide)(m)
|
=
|
AMP
|
+
|
diphosphate
|
+
|
(deoxyribonucleotide)(n+m)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
intracellular
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochemistry
40:13158-13166
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure and backbone dynamics of the human DNA ligase IIIalpha BRCT domain.
|
|
V.V.Krishnan,
K.H.Thornton,
M.P.Thelen,
M.Cosman.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BRCT (BRCA1 carboxyl terminus) domains are found in a number of DNA repair
enzymes and cell cycle regulators and are believed to mediate important
protein-protein interactions. The DNA ligase IIIalpha BRCT domain partners with
the distal BRCT domain of the DNA repair protein XRCC1 (X1BRCTb) in the DNA base
excision repair (BER) pathway. To elucidate the mechanisms by which these two
domains can interact, we have determined the solution structure of human ligase
consists of a
beta2beta1beta3beta4 parallel sheet with a two-alpha-helix bundle packed against
one face of the sheet. This fold is conserved in several proteins having a wide
range of activities, including X1BRCTb [Zhang, X. D., et al. (1998) EMBO J. 17,
exists as a dimer in solution, but an insufficient number of
NOE restraints precluded the determination of the homodimer structure. However,
13C isotope-filtered and hydrogen-deuterium exchange experiments indicate that
the N-terminus, alpha1, the alpha1-beta2 loop, and the three residues following
alpha2 are involved in forming the dimer interface, as similarly observed in the
structure of X1BRCTb. NOE and dynamic data indicate that several residues
(837-844) in the N-terminal region appear to interconvert between helix and
random coil conformations. Further studies of other BRCT domains and of their
complexes are needed to address how these proteins interact with one another,
and to shed light on how mutations can lead to disruption of function and
ultimately disease.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Rappas,
A.W.Oliver,
and
L.H.Pearl
(2011).
Structure and function of the Rad9-binding region of the DNA-damage checkpoint adaptor TopBP1.
|
| |
Nucleic Acids Res, 39,
313-324.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Mizushina
(2009).
Specific inhibitors of mammalian DNA polymerase species.
|
| |
Biosci Biotechnol Biochem, 73,
1239-1251.
|
 |
|
|
|
|
 |
A.Kumar,
W.S.Joo,
G.Meinke,
S.Moine,
E.N.Naumova,
and
P.A.Bullock
(2008).
Evidence for a structural relationship between BRCT domains and the helicase domains of the replication initiators encoded by the Polyomaviridae and Papillomaviridae families of DNA tumor viruses.
|
| |
J Virol, 82,
8849-8862.
|
 |
|
|
|
|
 |
E.Cotner-Gohara,
I.K.Kim,
A.E.Tomkinson,
and
T.Ellenberger
(2008).
Two DNA-binding and nick recognition modules in human DNA ligase III.
|
| |
J Biol Chem, 283,
10764-10772.
|
 |
|
|
|
|
 |
N.Dwivedi,
D.Dube,
J.Pandey,
B.Singh,
V.Kukshal,
R.Ramachandran,
and
R.P.Tripathi
(2008).
NAD(+)-dependent DNA ligase: a novel target waiting for the right inhibitor.
|
| |
Med Res Rev, 28,
545-568.
|
 |
|
|
|
|
 |
E.F.DeRose,
M.W.Clarkson,
S.A.Gilmore,
C.J.Galban,
A.Tripathy,
J.M.Havener,
G.A.Mueller,
D.A.Ramsden,
R.E.London,
and
A.L.Lee
(2007).
Solution structure of polymerase mu's BRCT Domain reveals an element essential for its role in nonhomologous end joining.
|
| |
Biochemistry, 46,
12100-12110.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.C.Zappulla,
A.S.Maharaj,
J.J.Connelly,
R.A.Jockusch,
and
R.Sternglanz
(2006).
Rtt107/Esc4 binds silent chromatin and DNA repair proteins using different BRCT motifs.
|
| |
BMC Mol Biol, 7,
40.
|
 |
|
|
|
|
 |
M.K.El-Tanani,
F.C.Campbell,
P.Crowe,
P.Erwin,
D.P.Harkin,
P.Pharoah,
B.Ponder,
and
P.S.Rudland
(2006).
BRCA1 suppresses osteopontin-mediated breast cancer.
|
| |
J Biol Chem, 281,
26587-26601.
|
 |
|
|
|
|
 |
M.Kobayashi,
F.Figaroa,
N.Meeuwenoord,
L.E.Jansen,
and
G.Siegal
(2006).
Characterization of the DNA binding and structural properties of the BRCT region of human replication factor C p140 subunit.
|
| |
J Biol Chem, 281,
4308-4317.
|
 |
|
|
|
|
 |
N.Puebla-Osorio,
D.B.Lacey,
F.W.Alt,
and
C.Zhu
(2006).
Early embryonic lethality due to targeted inactivation of DNA ligase III.
|
| |
Mol Cell Biol, 26,
3935-3941.
|
 |
|
|
|
|
 |
T.Takeuchi,
T.Ishidoh,
H.Iijima,
I.Kuriyama,
N.Shimazaki,
O.Koiwai,
K.Kuramochi,
S.Kobayashi,
F.Sugawara,
K.Sakaguchi,
H.Yoshida,
and
Y.Mizushina
(2006).
Structural relationship of curcumin derivatives binding to the BRCT domain of human DNA polymerase lambda.
|
| |
Genes Cells, 11,
223-235.
|
 |
|
|
|
|
 |
P.T.Beernink,
M.Hwang,
M.Ramirez,
M.B.Murphy,
S.A.Doyle,
and
M.P.Thelen
(2005).
Specificity of protein interactions mediated by BRCT domains of the XRCC1 DNA repair protein.
|
| |
J Biol Chem, 280,
30206-30213.
|
 |
|
|
|
|
 |
J.N.Glover,
R.S.Williams,
and
M.S.Lee
(2004).
Interactions between BRCT repeats and phosphoproteins: tangled up in two.
|
| |
Trends Biochem Sci, 29,
579-585.
|
 |
|
|
|
|
 |
R.S.Williams,
M.S.Lee,
D.D.Hau,
and
J.N.Glover
(2004).
Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
|
| |
Nat Struct Mol Biol, 11,
519-525.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Rodriguez,
X.Yu,
J.Chen,
and
Z.Songyang
(2003).
Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
|
| |
J Biol Chem, 278,
52914-52918.
|
 |
|
|
|
|
 |
R.S.Williams,
and
J.N.Glover
(2003).
Structural consequences of a cancer-causing BRCA1-BRCT missense mutation.
|
| |
J Biol Chem, 278,
2630-2635.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.J.Derbyshire,
B.P.Basu,
L.C.Serpell,
W.S.Joo,
T.Date,
K.Iwabuchi,
and
A.J.Doherty
(2002).
Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor.
|
| |
EMBO J, 21,
3863-3872.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.J.Derbyshire,
B.P.Basu,
T.Date,
K.Iwabuchi,
and
A.J.Doherty
(2002).
Purification, crystallization and preliminary X-ray analysis of the BRCT domains of human 53BP1 bound to the p53 tumour suppressor.
|
| |
Acta Crystallogr D Biol Crystallogr, 58,
1826-1829.
|
 |
|
|
|
|
 |
I.V.Martin,
and
S.A.MacNeill
(2002).
ATP-dependent DNA ligases.
|
| |
Genome Biol, 3,
REVIEWS3005.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|